Mar 27 2019
Auris Health celebrates being named the Red Dot: Best of the Best for product design. The award is an internationally sought-after recognition received by Auris for its Monarch Platform, a revolutionary flexible endoscopic platform featuring robotic technology that allows physicians to diagnose small, hard-to-reach peripheral nodules with greater precision than ever before.
The Red Dot Award is one of the world’s largest design competitions, originating in 1955. The award consists of three categories -- product design, brands and communication design, and design concepts. The competition is open to established designers and companies as well as to those setting out on their careers all over the globe.
The jury consists of roughly 40 experts, including designers, design professors and journalists from different fields, who come together for several days in order to assess the products. The jury tests each object individually, allowing them to evaluate not only the aesthetics of the product but also its functionality, longevity, peripherals and self-explanatory nature.
Auris Health and Fjord, Accenture Interactive, a global design and innovation consultancy, were at the forefront of the development of the Monarch Platform. When working to design the platform, the focus was on industrial design, design for manufacturing, user experience, user interface, visual design and high-fidelity prototyping.
“We are honored to receive recognition from the Red Dot judges for the Monarch Platform, which elevates design to push the boundaries of what is possible in medical robotics,” said Richard Leparmentier, Vice President of Engineering at Auris Health.
The result is an endoscopic system that is unified by a consistent, instinctive physical and digital interface that combines traditional endoscopic views with computer-assisted navigation based on 3D models of the patient’s lung anatomy. This is designed to provide physicians with a continuous view throughout the procedure — a significant improvement on existing bronchoscopic systems — thereby enhancing physician capabilities.
The desired “Red Dot” distinction has been the established international seal of outstanding design quality. Being named a Red Dot winner is a testimony to Monarch’s innovation and exceptional design.
Complications from bronchoscopy are rare and most often minor, but if they occur, may include breathing difficulty, vocal cord spasm, hoarseness, slight fever, vomiting, dizziness, bronchial spasm, infection, low blood oxygen, bleeding from biopsied site, or an allergic reaction to medications. Only rarely do patients experience other more serious complications (for example, collapsed lung, respiratory failure, heart attack and/or cardiac arrhythmia).
Adverse effects from both Mini-PCNL and Ureteroscopy include pain, urinary tract infection, fever, hematuria (presence of blood in urine), exposure to low levels of radiation, retained or residual stones.
Adverse effects from ureteroscopy may include pain, perforation or injury to the ureter, resulting in extravasation of fluid and urine (urinoma), stricture of the ureter with risk of subsequent obstruction (hydronephrosis needing further repair), rare avulsion of the ureter, urinary blood clots, residual stones.
PCNL access may result in minor and major adverse effects. Minor effects include fever and nephrostomy leak. Major adverse effects may include injuries to pleura, liver, spleen, large vessels with related bleeding, gallbladder, duodenum, jejunum, colon with related cutaneous fistula, fever, pain, ileus, elevated counts.
Major adverse effects related to stone removal may include infection and urosepsis, intravascular fluid overload, extravasation of fluid, and post percutaneous nephrolithotomy bleeding.